296 related articles for article (PubMed ID: 31376892)
1. Update on the Management of Respiratory Manifestations of the Antineutrophil Cytoplasmic Antibodies-Associated Vasculitides.
Thompson GE; Specks U
Clin Chest Med; 2019 Sep; 40(3):573-582. PubMed ID: 31376892
[TBL] [Abstract][Full Text] [Related]
2. [ANCA-associated vasculitis].
Krasselt ML; Holle JU
Inn Med (Heidelb); 2022 Sep; 63(9):947-960. PubMed ID: 35925127
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic algorithm for antineutrophil cytoplasmic antibody-associated systemic vasculitis.
Beketova TV
Ter Arkh; 2018 May; 90(5):13-22. PubMed ID: 30701885
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary involvement in primary systemic vasculitides.
Makhzoum JP; Grayson PC; Ponte C; Robson J; Suppiah R; Watts RA; Luqmani R; Merkel PA; Pagnoux C;
Rheumatology (Oxford); 2021 Dec; 61(1):319-330. PubMed ID: 33788906
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous Manifestations of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Micheletti RG; Chiesa Fuxench Z; Craven A; Watts RA; Luqmani RA; Merkel PA;
Arthritis Rheumatol; 2020 Oct; 72(10):1741-1747. PubMed ID: 32419292
[TBL] [Abstract][Full Text] [Related]
6. Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study.
Sada KE; Yamamura M; Harigai M; Fujii T; Dobashi H; Takasaki Y; Ito S; Yamada H; Wada T; Hirahashi J; Arimura Y; Makino H;
Arthritis Res Ther; 2014 Apr; 16(2):R101. PubMed ID: 24758294
[TBL] [Abstract][Full Text] [Related]
7. Lung involvement in ANCA-associated vasculitis.
Sacoto G; Boukhlal S; Specks U; Flores-Suárez LF; Cornec D
Presse Med; 2020 Oct; 49(3):104039. PubMed ID: 32650042
[TBL] [Abstract][Full Text] [Related]
8. The utility of the ACR/EULAR 2017 provisional classification criteria for granulomatosis with polyangiitis in Korean patients with antineutrophil cytoplasmic antibody-associated vasculitis.
Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Clin Exp Rheumatol; 2018; 36 Suppl 111(2):85-87. PubMed ID: 29185957
[TBL] [Abstract][Full Text] [Related]
9. Granulomatous Vasculitis.
Sharma A; Dogra S; Sharma K
Dermatol Clin; 2015 Jul; 33(3):475-87. PubMed ID: 26143427
[TBL] [Abstract][Full Text] [Related]
10. [Vasculitides and eosinophilic pulmonary diseases].
Kroegel C; Foerster M; Quickert S; Slevogt H; Neumann T
Z Rheumatol; 2018 Dec; 77(10):907-922. PubMed ID: 30367242
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis.
Sebastiani M; Manfredi A; Vacchi C; Cassone G; Faverio P; Cavazza A; Sverzellati N; Salvarani C; Luppi F
Clin Exp Rheumatol; 2020; 38 Suppl 124(2):221-231. PubMed ID: 32324122
[TBL] [Abstract][Full Text] [Related]
12. [Clinical manifestations of antineutrophil cytoplasmic antibodies associated vasculitis].
Morović-Vergles J; Culo MI; Sutić A
Lijec Vjesn; 2014; 136(7-8):228-31. PubMed ID: 25327013
[TBL] [Abstract][Full Text] [Related]
13. Relapsing subarachnoid hemorrhage as a clinical manifestation in microscopic polyangiitis: a case report and literature review.
Xie J; Jia E; Wang S; Yu Y; Li Z; Zhang J; Li J
Clin Rheumatol; 2022 Oct; 41(10):3227-3235. PubMed ID: 35690669
[TBL] [Abstract][Full Text] [Related]
14. [Anca-associated vasculitides in elderly people].
Jeleniewicz R
Wiad Lek; 2019; 72(9 cz 1):1691-1696. PubMed ID: 31586985
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of Pulmonary Manifestations in ANCA-Associated Vasculitis and Goodpasture Syndrome.
Fouka E; Drakopanagiotakis F; Steiropoulos P
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791316
[TBL] [Abstract][Full Text] [Related]
16. [Otologic Manifestations in Patients with ANCA Associated Vasculitis-Comparative Analysis among Microscopic Polyangiitis, Granulomatosis with Polyangiitis and Eosinophilic Granulomatosis with Polyangiitis].
Kawashima Y; Noguchi Y; Ito T; Mizushima K; Takahashi M; Kitamura K; Tsutsumi T
Nihon Jibiinkoka Gakkai Kaiho; 2016 Feb; 119(2):110-7. PubMed ID: 27149708
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of case-finding algorithms for the identification of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis in large healthcare administrative databases.
Sreih AG; Annapureddy N; Springer J; Casey G; Byram K; Cruz A; Estephan M; Frangiosa V; George MD; Liu M; Parker A; Sangani S; Sharim R; Merkel PA;
Pharmacoepidemiol Drug Saf; 2016 Dec; 25(12):1368-1374. PubMed ID: 27804171
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of large vessel vasculitis in ANCA-associated vasculitis: a retrospective cohort study.
Coattrenec Y; Muller YD; Spoerl D; Lobrinus JA; Seebach JD
Rheumatol Int; 2021 Dec; 41(12):2147-2156. PubMed ID: 34559277
[TBL] [Abstract][Full Text] [Related]
19. Current landscape of antineutrophil cytoplasmic antibody-associated vasculitis: classification, diagnosis, and treatment.
Lally L; Spiera R
Rheum Dis Clin North Am; 2015; 41(1):1-19, vii. PubMed ID: 25399936
[TBL] [Abstract][Full Text] [Related]
20. How to improve the histopathological diagnosis of systemic vasculitides in daily practice?
Honsová E
Cesk Patol; 2020; 56(2):68-73. PubMed ID: 32493022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
